STOCK BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

SCHEDULE OF STOCK-BASED COMPENSATION

Stock-based compensation, including stock options, warrants and restricted stock, expense is included in the consolidated statement of operations as follows:

	Years Ended December 31,
	2021		2020
Research and development	$	73,447	$	65,433
Sales and marketing		224,076		160,480
General and administrative		7,258,759		1,601,095
Total	$	7,556,282	$	1,827,008

SCHEDULE OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following table reflects the stock option activity:

	Number of Shares			Weighted Average Exercise Price			Contractual Life (Years)
Outstanding at December 31, 2019		996,645		$	2.92			5.73
Assumed as part of the Merger		61,440		$	46.95
Granted		896,269		$	3.06
Exercised		(6,817	)	$	(2.45	)
Forfeitures		(27,268	)	$	(2.86	)
Outstanding at December 31, 2020		1,920,269		$	4.40			8.66
Exercised		(555,004	)	$	(2.72	)
Forfeitures		(26,590	)	$	(2.52	)
Outstanding at December 31, 2021		1,338,675		$	5.14			8.26

SCHEDULE OF STOCK-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

The Company uses the following inputs when valuing stock-based awards.

	For the Years Ended December 31,
	2021		2020
Expected life (years)		n/a		5.0
Risk-free interest rate		n/a		0.38	%
Expected volatility		n/a		89.76	%
Total grant date fair value		n/a	$	1.83 to $2.81

SCHEDULE OF RESTRICTED STOCK ACTIVITY

The following table reflects the restricted stock activity:

	Number of Shares			Weighted Average Grant Price
Outstanding at December 31, 2019		-		$	-
Granted		1,087,618		$	5.27
Vested		(15,115	)	$	(3.17	)
Outstanding at December 31, 2020		1,072,503		$	5.30
Granted		622,000		$	3.91
Vested		(1,201,891	)	$	5.71
Forfeitures		(42,612	)	$	3.17
Outstanding at December 31, 2021		450,000		$	2.48